| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.29 | $4.21 | 1.92% | 33.00x | 17.88x | 9.79x | 18.36x | 0.35x | -$74.32M | -4.83% | $83.79M | 0.23 | $1.62B | 39.68 | ||
| CORT | CORCEPT THERAPEUTICS INC | $70.07 | $39.01 | 79.62% | 46.40x | 33.00x | 7.75x | 9.20x | 0.64x | $194.62M | 2.60% | $833.74M | 7.82 | $7.58B | 68.33 | ||
| FENC | FENNEC PHARMACEUTICALS INC | $13.58 | $3.08 | 341.50% | 339.50x | 47.04x | 7.19x | 9.75x | 1.38x | $3.15M | 0.66% | $49.19M | 1.40 | $430.76M | 152.43 | ||
| TGTX | TG THERAPEUTICS INC | $62.71 | $20.11 | 211.78% | 80.40x | 61.17x | 9.83x | 16.57x | 1.11x | $85.56M | 0.97% | $572.13M | 4.06 | $9.80B | 49.92 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $293.81 | $71.68 | 309.90% | 110.87x | 30.29x | 23.11x | 6.11x | 1.45x | $90.43M | 1.54% | $961.76M | 48.18 | $6.97B | 70.82 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.33 | $7.84 | 248.54% | 124.23x | 88.22x | 7.04x | 14.17x | 1.17x | $59.71M | 1.67% | $243.97M | 1.86 | $3.54B | 75.60 | ||
| RPRX | ROYALTY PHARMA PLC | $68.68 | $34.40 | 99.67% | 44.89x | 12.55x | 11.71x | 4.02x | 0.74x | $2.89B | 9.45% | $9.80B | 21.96 | $47.47B | 45.49 | ||
| KRYS | KRYSTAL BIOTECH INC | $298.55 | $75.78 | 293.99% | 38.98x | 38.10x | 18.81x | 6.16x | 2.16x | $310.08M | 3.51% | $1.44B | 48.48 | $8.39B | 31.61 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $95.11 | $14.33 | 563.87% | 66.51x | 72.48x | 7.86x | 10.52x | 3.60x | $197.20M | 2.65% | $710.19M | 9.08 | $7.40B | 48.67 | ||
| HALO | HALOZYME THERAPEUTICS INC | $95.97 | $73.47 | 30.63% | 22.63x | 10.60x | 6.06x | -198.08x | 0.52x | $885.88M | 8.11% | -$55.24M | -0.49 | $13.16B | 16.34 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $240.71 | $128.22 | 87.73% | 66.13x | 15.75x | 3.30x | 3.69x | 0.63x | $1.65B | 10.61% | $4.19B | 64.79 | $19.04B | 16.62 | ||
| ADMA | ADMA BIOLOGICS INC | $13.63 | $6.78 | 100.99% | 17.25x | 16.91x | 5.87x | 6.90x | 1.27x | $132.91M | 4.36% | $438.51M | 1.96 | $3.10B | 12.26 | ||
| VCEL | VERICEL CORP | $57.88 | $8.37 | 591.14% | 87.70x | 76.68x | 9.14x | 7.69x | 3.18x | $57.89M | 1.95% | $384.17M | 7.51 | $2.91B | 53.97 | ||
| TECH | BIO-TECHNE CORP | $72.63 | $15.86 | 358.04% | 66.03x | 34.97x | 9.27x | 5.27x | 1.97x | $308.20M | 2.71% | $2.17B | 13.81 | $11.35B | 33.99 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.40 | $7.78 | 20.80% | 7.40x | 8.23x | 3.78x | 2.34x | 1.42x | $87.07M | 15.60% | $238.92M | 4.02 | $438.42M | 4.56 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $534.20 | $142.76 | 274.20% | 34.09x | 28.74x | 10.46x | 6.48x | 2.22x | $3.20B | 2.36% | $20.91B | 82.48 | $136.94B | 27.19 | ||
| INCY | INCYTE CORP | $119.09 | $52.29 | 127.74% | 56.98x | 34.50x | 4.03x | 4.30x | 0.82x | $684.87M | 2.83% | $5.64B | 27.76 | $21.03B | 23.44 | ||
| EXEL | EXELIXIS INC | $68.50 | $30.98 | 121.11% | 19.86x | 19.56x | 6.77x | 9.11x | 1.33x | $1.16B | 6.87% | $1.83B | 7.43 | $16.57B | 14.83 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.01 | $27.82 | 18.65% | 10.68x | 8.61x | 1.95x | 1.81x | 0.71x | $322.93M | 16.75% | $1.07B | 18.36 | $1.44B | 5.31 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $957.76 | $480.41 | 99.36% | 20.37x | 13.64x | 5.76x | 2.96x | 1.06x | $3.83B | 3.93% | $33.50B | 329.39 | $98.13B | 15.71 | ||
| UTHR | UNITED THERAPEUTICS CORP | $584.10 | $206.78 | 182.48% | 20.44x | 21.82x | 7.82x | 3.96x | 2.27x | $867.20M | 3.48% | $6.28B | 146.98 | $23.69B | 14.66 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $1.91 | $6.21 | -69.34% | 3.23x | -46.69x | N/A | 1.47x | 0.16x | -$21.06M | -5.98% | $139.32M | 0.76 | $197.67M | 157.26 | ||
| VCYT | VERACYTE INC | $24.23 | $9.49 | 155.28% | 15.24x | 12.37x | 3.35x | 1.36x | 3.26x | $161.95M | 8.30% | $1.43B | 17.80 | $1.79B | 12.59 |